Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most common chronic liver disease worldwide, with the Middle East and North Africa (MENA) being severely affected.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback